By Heather Murdock
Merck & Co. and Qiagen NV (QGEN) will fund a program in Rwanda to screen and vaccinate women against cervical cancer, the New Times reported, citing Agnes Binagwaho, permanent secretary in the Health Ministry.
Merck will provide more than 2 million doses of its Gardasil vaccine to the government at no charge, while Qiagen will deliver 250,000 Human Papilloma Virus screening tests to the state, the Kigali-based newspaper said.
Leave a Reply